Immunogen reported $1.25M in Interest Expense on Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Abbvie ABBV:US $ 548M 32M
Amgen AMGN:US $ 295M 40M
Bristol Myers Squibb BMY:US $ 326M 3M
Eli Lilly And LLY:US $ 84.9M 3.5M
Emergent Biosolutions EBS:US $ 8.2M 0.8M
Halozyme Therapeutics HALO:US $ 1.76M 0.3M
Immunogen IMGN:US $ 1.25M 0.9M
Intrexon XON:US $ 2.07M 2.82M
Karyopharm Therapeutics KPTI:US $ 6.68M 1.26M
Nektar Therapeutics NKTR:US $ 7.53M 0.6M
Novartis NVS:US $ 201M 5M
Pfizer PFE:US $ 322M 6M
Regeneron Pharmaceuticals REGN:US $ 13.6M 0.5M